Last Updated:
Access Report
Name Designation Appointment Date Status
Md Zibrail

Appointed as Director since December 2023

 Director 11-Dec-2023 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Hasan Ali

Appointed as Director since December 2023

 Director 11-Dec-2023 Current
Mouaz Usmani

Appointed as Director since December 2023

 Director 11-Dec-2023 Current

People Timeline

Explore the timeline of key personnel in Moonpro Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address R3-A2/38 A Ground Floor, Block R5 Mohan Garden, New Delhi Delhi, 110059, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110059
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Moonpro Pharmaceuticals Private Limited?
You can contact Moonpro Pharmaceuticals Private Limited through their registered address at R3-A2/38 A Ground Floor, Block R5 Mohan Garden, New Delhi Delhi, 110059, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Moonpro Pharmaceuticals Private Limited?
The current directors of Moonpro Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MD ZIBRAIL
  • Hasan Ali
  • Mouaz Usmani
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available